Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof

• 1. 肿瘤坏死因子相关细胞凋亡诱导配体受体的选择性抗体及其制备药物的用途 [P] . 中国专利： CN100482276C . 2009.04.29
• 2. 肿瘤坏死因子相关细胞凋亡诱导配体受体的选择性抗体及其用途 [P] . 中国专利： CN1655814A . 2005-08-17
• 3. Antibodies selective for tumor necrosis factor-related apoptosis-inducing ligand receptors and uses thereof [P] . 日本专利： JP4156238B2 . 2008-09-24

  机译： 对肿瘤坏死因子相关的凋亡诱导配体受体具有选择性的抗体及其用途

• 4. AN ANTIBODY SELECTIVE FOR A TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND RECEPTOR AND USES THEREOF [P] . NO338228B1 . 2016-08-08

  机译： 肿瘤坏死因子相关的凋亡诱导配体受体的抗体选择及其用途

• 5. AN ANTIBODY SELECTIVE FOR A TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND RECEPTOR AND USES THEREOF [P] . NO338458B1 . 2016-08-15

  机译： 肿瘤坏死因子相关的凋亡诱导配体受体的抗体选择及其用途

• 1. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in glioma U87 cells [J] . Fei Zhong, Xiangyuan Wu, Chunkui Shao, 中国神经再生研究：英文版 . 2010,第017期
• 2. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in glioma U87 cells [J] . Fei Zhong, Xiangyuan Wu, Chunkui Shao, 中国神经再生研究（英文版） . 2010,第017期
• 3. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. [J] . Shanker A, Brooks AD, Tristan CA, Journal of the National Cancer Institute . 2008,第9期
• 4. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo [J] . Y. Zeng, X. X. Wu, M. Fiscella, International journal of oncology . 2006,第2期
• 5. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation. [J] . Tashiro H, Itamoto T, Ohdan H, Transplant international : . 2004,第10期
• 6. Effect of Molecular Size of PEGylated tumor necrosis factor factor-related apoptosis apoptosis-inducing ligand(TRAIL) : T The Biological Activity and he Stability [C] . Tae Hyung Kim, Su Young Chae, Seung Min Byun, Annual meeting exposition of the Controlled Release Society . 2009
• 7. Modulation of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors in a human osteoclast model in vitro. [D] . McManus, Stephen. 2011
• 8. Expression of osteoprotegerin receptor activator of nuclear factor kappa-B ligand tumor necrosis factor-related apoptosis-inducing ligand stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines [O] . Vivian Labovsky, Valeria B Fernández Vallone, Leandro M Martinez, 2012
• 9. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3 [O] . Harris Perlman, Nadine Nguyen, Hongtao Liu, 2003
• 10. Modulators of Response to Tumor Necrosis-Related Apoptosis-Inducing Ligand (TRAIL) Therapy in Ovarian Cancer [R] . Behbakht, K. 2009

• 1. Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells [J] . DietmarJacob ,GuidoSchumacher ,MarcusBahra . 世界胃肠病学杂志：英文版 . 2005,第17期
• 2. Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells [J] . Yi-YingWu ,Hwei-FangTsai ,We-ChengLin . 世界胃肠病学杂志：英文版 . 2004,第16期
• 3. Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29 [J] . Xiang-MingXu ,ChaoHe ,Xiao-TongHu . 世界胃肠病学杂志：英文版 . 2003,第5期
• 4. 具有受体选择性的新型肿瘤坏死因子突变体的蛋白质工程研究 [C] . 王国力 ,周晓巍 ,黄培堂 . 中国科协首届学术年会 . 1999
• 5. 具有立体选择性环氧化物水解酶产生菌的筛选及手性β受体阻滞剂的生物法制备 [A] . 张正方 . 2010